| |
|
 |
| Aminolab Pharma Brings Home Out-Sourcing
Targets $90 M Israeli Co.`s Spend Overseas | | “For the first time local companies have a one-stop-shop where all of their pre-clinical and clinical development services can be carried out in certified GMP and GLP facilities,” says Shimon Amselem, CEO. | | read full article... |
|
|
 |
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
 |
 | Slow Down, You Eat Too Fast
Device Helps User Take Smaller Bites | | Nobesity offers a safe, non-invasive product that helps people overcome one of the underlying causes of obesity -- fast eating. | | read full article... |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
 |
| SoluBest Raises $5 Million
Michael Sheckler Appointed CEO | | SoluBest’s new CEO Michael Sheckler plans to raise the company’s visibility in the U.S. as it partners with companies to improve the solubility of drugs and improve their therapeutic potential. | | read full article... |
|
|
|
|
|
| |
|
 |
| Personalized Treatment For Cancer
Optimata Publishes Successful Angiogenesis Study | | “The Optimata Virtual Patient showed almost 90 percent accuracy in predicting tumor growth inhibition of the patient’s biopsy Xenografts when treated by various cytotoxics and targeted angiogenic inhibitors,” said Prof. Agur, founder and CSO of Optimata. | | read full article... |
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
| |
|
top of the page
|
|
